In contrast to the in vivo inactivation of STK25 or MST3, we observed that the genetic knockout of MST4 in mice has no impact on the development of diet-induced MASLD, glucose intolerance, or insulin resistance [27]. This evidence concerns the gene STK25 and metabolic dysfunction-associated steatotic liver disease.